We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

190 hedge funds and large institutions have $1.4B invested in Dr. Reddy's Laboratories in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 79 increasing their positions, 55 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 7

44% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 55

9% more funds holding

Funds holding: 174190 (+16)

1.76% more ownership

Funds ownership: 72.52%74.28% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less capital invested

Capital invested by funds: $1.41B → $1.4B (-$7.35M)

54% less call options, than puts

Call options by funds: $707K | Put options by funds: $1.52M

Holders
190
Holders Change
+16
Holders Change %
+9.2%
% of All Funds
5.12%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
79
Reduced
55
Closed
7
Calls
$707K
Puts
$1.52M
Net Calls
-$814K
Net Calls Change
-$872K
Name Holding Trade Value Shares
Change
Change in
Stake
GF
101
Gabelli Funds
New York
$913K -$166K -15,000 -15%
NFA
102
Nationwide Fund Advisors
Ohio
$830K +$607K +55,000 +275%
Ameriprise
103
Ameriprise
Minnesota
$828K -$204K -18,475 -20%
Mackenzie Financial
104
Mackenzie Financial
Ontario, Canada
$807K +$336K +30,460 +72%
Fifth Third Bancorp
105
Fifth Third Bancorp
Ohio
$805K +$66.2K +5,995 +9%
AAM
106
Azzad Asset Management
Virginia
$799K +$345K +31,280 +76%
AL
107
Airain Ltd
Guernsey
$750K -$753K -68,245 -50%
VOYA Investment Management
108
VOYA Investment Management
Georgia
$716K -$71.4K -6,470 -9%
B
109
Bailard
California
$643K +$276K +25,000 +100%
Capital Fund Management (CFM)
110
Capital Fund Management (CFM)
France
$636K +$635K +57,500 New
PA
111
Pinnacle Associates
New York
$633K +$16.8K +1,525 +3%
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$590K +$181K +16,405 +45%
AIA
113
Avalon Investment & Advisory
Texas
$586K +$58.7K +5,320 +11%
GC
114
Guggenheim Capital
Illinois
$578K -$53.7K -4,860 -9%
LG
115
Leuthold Group
Minnesota
$519K
TI
116
Trexquant Investment
Connecticut
$503K +$88.3K +8,000 +21%
CAM
117
Centre Asset Management
New York
$486K
PSCM
118
Prince Street Capital Management
New York
$475K -$1.48M -134,000 -76%
LCM
119
Logan Capital Management
Pennsylvania
$464K +$463K +41,965 New
WAM
120
World Asset Management
Michigan
$449K -$29.2K -2,645 -6%
NMC
121
Nine Masts Capital
Hong Kong
$446K -$2.29M -207,470 -84%
PG
122
PEAK6 Group
Illinois
$444K +$443K +40,140 New
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
$430K -$381K -34,490 -47%
GA
124
Geneva Advisors
Illinois
$430K -$136K -12,305 -24%
NEI
125
Northwest & Ethical Investments
Ontario, Canada
$407K

RDY Hedge Fund Activity: Q2 2015 in Review

190 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2015, worth a combined $1.4B — down 0.52% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new RDY positions and 7 closed out — a net gain of 17 holders — while 79 added to existing stakes and 55 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $16.2M. The largest seller was Sectoral Asset Management, cutting an estimated $37.6M.

  • 190 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2015, up from 174 in Q1 2015.
  • Funds reported $1.4B of Dr. Reddy's Laboratories stock for Q2 2015, down 0.52% quarter-over-quarter.
  • 24 funds opened new Dr. Reddy's Laboratories positions in Q2 2015 and 7 closed out, a net change of +17 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2015 was AQR Capital Management, an estimated $16.2M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2015 was Sectoral Asset Management, an estimated $37.6M sold.

Based on aggregated 13F filings for Q2 2015.